Critical Comparison: Valuence Merger Corp. I (VMCA) and Its Rivals

Institutional and Insider Ownership

52.2% of Valuence Merger Corp. I shares are held by institutional investors. Comparatively, 54.5% of shares of all “Holding & other investment offices” companies are held by institutional investors. 47.0% of Valuence Merger Corp. I shares are held by company insiders. Comparatively, 27.3% of shares of all “Holding & other investment offices” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Volatility and Risk

Valuence Merger Corp. I has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. Comparatively, Valuence Merger Corp. I’s rivals have a beta of 0.02, meaning that their average stock price is 98% less volatile than the S&P 500.

Profitability

This table compares Valuence Merger Corp. I and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Valuence Merger Corp. I	N/A	-12.23%	3.41%
Valuence Merger Corp. I Competitors	11.89%	-46.64%	1.71%

Earnings & Valuation

This table compares Valuence Merger Corp. I and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Valuence Merger Corp. I	N/A	$4.77 million	72.00
Valuence Merger Corp. I Competitors	$1.04 billion	$78.62 million	37.95

Valuence Merger Corp. I’s rivals have higher revenue and earnings than Valuence Merger Corp. I. Valuence Merger Corp. I is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Valuence Merger Corp. I rivals beat Valuence Merger Corp. I on 5 of the 9 factors compared.

Valuence Merger Corp. I Company Profile

Valuence Merger Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology in Asia. The company was incorporated in 2021 and is based in Orinda, California.